United Therapeutics Corp

XNAS:UTHR

542.66

-0.73 (-0.13%)

6:27:10 PM EDT: $542.66 0.00 (0.00%)

Market Cap (Intraday)	23.04B
Current PE	17.89
Forward PE	19.17
2yr Forward PE	16.44

See more stats

Estimates Current Quarter

Revenue	$810.43 Million
Adjusted EPS	$7.17

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

United Therapeutics Corp Stock, XNAS:UTHR

1000 Spring Street, Silver Spring, Maryland 20910

United States of America

Phone: +1.301.608.9292

Number of Employees: 1305

http://www.unither.com

Description

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.